Children with asthma and other respiratory diseases often struggle with infections and inflammation. A recent narrative review explores how the respiratory microbiome, including its composition and metabolites, might play a role in these conditions. The study focuses on children as the population of interest. It looks at colonization and dysbiosis within the airway. No specific medications were tested in this review. The authors did not report safety signals or adverse events because this was a review of existing ideas rather than a clinical trial. The review provides new ideas and directions for research on pathogenesis and clinical precision treatment. Because this is a narrative review, it summarizes concepts rather than testing a specific hypothesis with a large group of patients. The evidence here is about potential pathways and future research needs. It does not confirm a cure or a specific treatment yet. This work helps scientists think about how to target the microbiome for better care.
Respiratory microbiome composition in children offers new ideas for precision treatment of respiratory diseases and asthmaNew ideas for treating children with asthma and respiratory infections
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Consider the respiratory microbiome as a direction for future research on pediatric respiratory disease pathogenesis.
This narrative review focuses on the respiratory microbiome, including its composition, metabolites, and colonization status within pediatric populations. The scope covers children affected by respiratory infections, allergic airway inflammation, asthma, and other respiratory diseases. The authors discuss how these factors relate to the broader context of respiratory health in this age group.
The authors provide new ideas and directions for research on pathogenesis and clinical precision treatment based on the available information. No specific quantitative results, p-values, or confidence intervals were reported in this source. Safety data, including adverse events and tolerability, were not reported in this source.
The review does not establish causal links between microbiome changes and clinical outcomes. The findings are intended to guide future research rather than inform immediate clinical practice. Limitations regarding the lack of specific data are acknowledged through the absence of reported numerical outcomes.
What this means for you:
This review offers new ideas for precision treatment of children with respiratory diseases. More on Asthma
Oral bacterial lysates reduce wheezing frequency and infection rates in children with asthma
Oral bacterial lysates may improve outcomes for children with asthma
This meta-analysis of 2,893 children with asthma found that oral bacterial lysates (OBLs) significantly reduced wheezing frequency (MD = -3.…
A review of data suggests that oral bacterial lysates could reduce wheezing and infection rates in children living with asthma.
Polygenic risk scores validate IL-1 signaling role in childhood asthma, supporting IL1R1 antagonist repurposing
New data links specific proteins to asthma risk in children
This meta-analysis of two family-based cohorts found that externally derived asthma polygenic risk scores (GBMI-PRS) are valid in children a…
Researchers found that certain genetic markers and protein levels can help identify the underlying causes of childhood asthma.
Pharmacist-led telepharmacy may improve medication adherence and reduce blood pressure in patients with NCDs
Pharmacist Led Telepharmacy May Improve Medication Adherence For Chronic Illness
This systematic review analyzed 21 trials involving 5440 participants to evaluate pharmacist-led telepharmacy for managing non-communicable …
Remote pharmacist services through phone or video may help patients with high blood pressure and diabetes stick to their daily medication pl…
Structured physical activity improves FEV1% predicted by 5.79 and PAQLQ scores in patients with asthma
Structured Physical Activity Shows Benefits for People with Asthma
This meta-analysis of trials involving structured physical activity for at least 6 weeks found significant improvements in FEV1% predicted (…
Structured physical activity programs of at least 6 weeks may improve lung function and quality of life for people living with asthma.
View Original Abstract ↓
Respiratory diseases are common and frequently occurring illnesses in children. In recent years, studies have confirmed that the respiratory microbiome is closely associated with the susceptibility and severity of respiratory diseases in children, and its microbial composition and metabolites are involved in the occurrence and development of respiratory infections, allergic airway inflammation, asthma and other disorders. Based on the cutting-edge research findings of the past 2–3 years, this review systematically summarizes the composition and sources of the respiratory microbiome in children, the characteristics of its colonization and dysbiosis, the interaction mechanisms with the host immune system, as well as the correlation rules with common respiratory diseases. It also focuses on elaborating novel therapeutic strategies such as probiotic therapy, phage therapy, and antimicrobial peptide (AMP) therapy, aiming to provide new ideas and directions for the research on the pathogenesis and clinical precision treatment of childhood respiratory diseases.
Real-world meta-analysis supports pembrolizumab for advanced NSCLC with high PD-L1
Real-world data confirms pembrolizumab offers long-term survival for advanced lung cancer patients
Related in Pulmonology & Critical Care
FDA Approves Provocholine (methacholine chloride) for Bronchial Airway Hyperreactivity Diagnosis
FDA approves new test to help diagnose asthma in certain patients
The FDA approved Provocholine (methacholine chloride) for diagnosing bronchial airway hyperreactivity in adults and children aged 5 years an…
The FDA approved Provocholine, a drug used in a breathing test to diagnose airway hyperreactivity in people aged 5 and older who may have as…
Tislelizumab plus chemotherapy improves survival in extensive-stage small cell lung cancer
Immunotherapy combo extends survival in small cell lung cancer
This phase 3 RCT evaluated tislelizumab plus chemotherapy versus placebo plus chemotherapy in previously untreated extensive-stage small cel…
Adding tislelizumab to chemo helped people with extensive-stage small cell lung cancer live 2 months longer, a phase 3 trial shows.
Lower PEEP may increase ventilator-free days in ventilated patients without ARDS
Lower breathing pressure settings showed modest benefits for some critically ill patients without lung injury
This Bayesian re-analysis of an RCT in 980 invasively ventilated critically ill patients without ARDS found that lower PEEP (0-5 cm H2O) com…
A re-analysis of data found that using the lowest safe breathing pressure might help some patients breathe easier. However, the overall bene…
Machine learning models show moderate accuracy predicting neoadjuvant immunotherapy response in NSCLC
Machine learning models predict how well lung cancer patients respond to immunotherapy
This systematic review and meta-analysis of 44 models found that machine learning predicts neoadjuvant immunotherapy response in resectable …
A new analysis of 44 models shows computer programs can guess which lung cancer patients will benefit from immunotherapy, though the study h…
From Other Specialties
Individualized six-phase antithrombotic strategy leads to left ventricular thrombus resolution and neurological recovery
New strategy helps manage heart blood clots after heart attack
This case report describes an individualized six-phase antithrombotic strategy for a 27-year-old male with myocardial infarction, stroke, hy…
A tailored six-phase treatment plan helped a young man recover fully from a stroke and heart attack while successfully clearing dangerous bl…
Heterogeneous definitions and clinical inconsistencies currently hinder the accurate identification of treatment-resistant depression
New ways to define treatment resistant depression are emerging
This narrative review examines the phenotypic definition of treatment-resistant depression (TRD) and its associated biological correlates. T…
Doctors struggle to treat some types of depression because the current definition is inconsistent. New research looks at how biology and beh…
HIFU combined with ethanol ablation or GnRH-a improves intraoperative outcomes for adenomyosis treatment
HIFU Combined With Medication Shows Better Results for Adenomyosis
This network meta-analysis of 1,685 patients evaluated HIFU combined with various medications compared to HIFU alone for adenomyosis. The an…
Combining high-intensity focused ultrasound (HIFU) with specific medications may improve treatment outcomes for people with adenomyosis.
Risk-optimized use of Janus kinase inhibitors in Japanese patients with rheumatoid arthritis depends on comorbidities
New evidence helps doctors choose safer arthritis treatments for seniors
This narrative review examines the safety and risk profile of Janus kinase inhibitors (JAKi) for rheumatoid arthritis specifically within th…
Doctors are moving toward personalized plans for rheumatoid arthritis, focusing on a patient's specific health risks rather than just their …